27236033|t|LDLR, ApoB and ApoE genes polymorphisms and classical risk factors in premature coronary artery disease
27236033|a|Lipoproteins play a central role in the development of atherosclerotic disease. So, with their ability to affect lipid levels, the LDLR, ApoB and ApoE polymorphisms could be one of the factors influencing development of atherosclerosis. This hypothesis has been tested in different populations with conflicting results. The purpose of the present study was to investigate the association between the LDLR, ApoB and ApoE genes polymorphisms with premature CAD (PCAD) in Egyptians. One hundred thirty-five patients of PCAD and one hundred thirty-two ages and sex matched control subjects were included in the study. LDLR and ApoB genes polymorphisms were analyzed by polymerase chain reaction (PCR). The ApoE genotypes were identified by multiplex amplification refractory mutation system (multi-AMRS). We found that LDLR A(+)A(+) genotype, ApoB X(+) allele and ApoE E4 allele increased the risk of PCAD by 1.8, 2.1 and 12.1 respectively. The present study proved that smoking, metabolic syndrome, ApoB X(+)X(+) genotype and ApoE E4 allele were independent risk factors for the development of PCAD. This is the first study investigate the association between low density lipoprotein receptor, apolipoprotein B and apolipoprotein E genes polymorphisms with PCAD and lipid levels in Egyptians and we concluded that the LDLR A(+)A(+) genotype, ApoB X(+) allele and ApoE E4 allele may be associated with an increased risk for development of PCAD by elevated levels of total cholesterol (TC) and low density lipoprotein (LDLc). The coexistence of CAD risk factors with LDLR A(+)A(+) genotype, ApoB X(+) allele and ApoE E4 allele may increase the risk of the development of PCAD in Egyptian patients.
27236033	0	4	LDLR	T017	UMLS:C1366529
27236033	6	10	ApoB	T017	UMLS:C1412471
27236033	15	25	ApoE genes	T017	UMLS:C1412481
27236033	54	66	risk factors	T033	UMLS:C0035648
27236033	70	103	premature coronary artery disease	T038	UMLS:C1867743
27236033	104	116	Lipoproteins	T103	UMLS:C0023820
27236033	159	182	atherosclerotic disease	T038	UMLS:C0004153
27236033	217	229	lipid levels	T033	UMLS:C0428460
27236033	235	239	LDLR	T017	UMLS:C1366529
27236033	241	245	ApoB	T017	UMLS:C1412471
27236033	250	254	ApoE	T017	UMLS:C1412481
27236033	324	339	atherosclerosis	T038	UMLS:C0004153
27236033	366	372	tested	T170	UMLS:C0392366
27236033	504	508	LDLR	T017	UMLS:C1366529
27236033	510	514	ApoB	T017	UMLS:C1412471
27236033	519	529	ApoE genes	T017	UMLS:C1412481
27236033	549	562	premature CAD	T038	UMLS:C1867743
27236033	564	568	PCAD	T038	UMLS:C1867743
27236033	573	582	Egyptians	T098	UMLS:C0337801
27236033	620	624	PCAD	T038	UMLS:C1867743
27236033	718	722	LDLR	T017	UMLS:C1366529
27236033	727	737	ApoB genes	T017	UMLS:C1412471
27236033	757	765	analyzed	T062	UMLS:C0936012
27236033	769	794	polymerase chain reaction	T062	UMLS:C0032520
27236033	796	799	PCR	T062	UMLS:C0032520
27236033	806	810	ApoE	T017	UMLS:C1412481
27236033	840	890	multiplex amplification refractory mutation system	T058	UMLS:C2732542
27236033	892	902	multi-AMRS	T058	UMLS:C2732542
27236033	919	932	LDLR A(+)A(+)	T017	UMLS:C1366529
27236033	943	952	ApoB X(+)	T017	UMLS:C1412471
27236033	953	959	allele	T017	UMLS:C0002085
27236033	964	971	ApoE E4	T017	UMLS:C1412481
27236033	972	978	allele	T017	UMLS:C0002085
27236033	1001	1005	PCAD	T038	UMLS:C1867743
27236033	1080	1098	metabolic syndrome	T038	UMLS:C0524620
27236033	1100	1113	ApoB X(+)X(+)	T017	UMLS:C1412471
27236033	1127	1134	ApoE E4	T017	UMLS:C1412481
27236033	1135	1141	allele	T017	UMLS:C0002085
27236033	1159	1171	risk factors	T033	UMLS:C0035648
27236033	1195	1199	PCAD	T038	UMLS:C1867743
27236033	1261	1293	low density lipoprotein receptor	T017	UMLS:C1366529
27236033	1295	1311	apolipoprotein B	T017	UMLS:C1412471
27236033	1316	1338	apolipoprotein E genes	T017	UMLS:C1412481
27236033	1358	1362	PCAD	T038	UMLS:C1867743
27236033	1367	1379	lipid levels	T033	UMLS:C0428460
27236033	1383	1392	Egyptians	T098	UMLS:C0337801
27236033	1419	1432	LDLR A(+)A(+)	T017	UMLS:C1366529
27236033	1443	1452	ApoB X(+)	T017	UMLS:C1412471
27236033	1453	1459	allele	T017	UMLS:C0002085
27236033	1464	1471	ApoE E4	T017	UMLS:C1412481
27236033	1472	1478	allele	T017	UMLS:C0002085
27236033	1539	1543	PCAD	T038	UMLS:C1867743
27236033	1556	1588	levels of total cholesterol (TC)	T058	UMLS:C0201950
27236033	1593	1616	low density lipoprotein	T058	UMLS:C0202116
27236033	1618	1622	LDLc	T058	UMLS:C0202116
27236033	1644	1647	CAD	T038	UMLS:C1867743
27236033	1648	1660	risk factors	T033	UMLS:C0035648
27236033	1666	1679	LDLR A(+)A(+)	T017	UMLS:C1366529
27236033	1690	1699	ApoB X(+)	T017	UMLS:C1412471
27236033	1700	1706	allele	T017	UMLS:C0002085
27236033	1711	1718	ApoE E4	T017	UMLS:C1412481
27236033	1719	1725	allele	T017	UMLS:C0002085
27236033	1770	1774	PCAD	T038	UMLS:C1867743
27236033	1778	1786	Egyptian	T098	UMLS:C0337801